Contrast sensitivity impairment in drug-na ïve Parkinson’s disease patients associates with early cognitive decline

ConclusionContrast sensitivity impairment in drug-na ïve PD patients associates with clinical demand for therapeutic intervention of cognitive decline as well as development of visual hallucinations in the early course of the disease.

http://link.springer.com/10.1007/s10072-020-04289-6

Source: Neurological Sciences - February 14, 2020 Category: Neurology Source Type: research